211 related articles for article (PubMed ID: 30364390)
1. Subcellular organization of UBE3A in human cerebral cortex.
Burette AC; Judson MC; Li AN; Chang EF; Seeley WW; Philpot BD; Weinberg RJ
Mol Autism; 2018; 9():54. PubMed ID: 30364390
[TBL] [Abstract][Full Text] [Related]
2. Subcellular organization of UBE3A in neurons.
Burette AC; Judson MC; Burette S; Phend KD; Philpot BD; Weinberg RJ
J Comp Neurol; 2017 Feb; 525(2):233-251. PubMed ID: 27339004
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
[TBL] [Abstract][Full Text] [Related]
4. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
5. Adult
Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
[TBL] [Abstract][Full Text] [Related]
6. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.
Condon KH; Ho J; Robinson CG; Hanus C; Ehlers MD
J Neurosci; 2013 Feb; 33(9):3799-814. PubMed ID: 23447592
[TBL] [Abstract][Full Text] [Related]
7. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
[TBL] [Abstract][Full Text] [Related]
8. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
[TBL] [Abstract][Full Text] [Related]
9. Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex.
Kim H; Kunz PA; Mooney R; Philpot BD; Smith SL
J Neurosci; 2016 Apr; 36(17):4888-94. PubMed ID: 27122043
[TBL] [Abstract][Full Text] [Related]
10.
Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
[TBL] [Abstract][Full Text] [Related]
11. GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.
Judson MC; Wallace ML; Sidorov MS; Burette AC; Gu B; van Woerden GM; King IF; Han JE; Zylka MJ; Elgersma Y; Weinberg RJ; Philpot BD
Neuron; 2016 Apr; 90(1):56-69. PubMed ID: 27021170
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
LaSalle JM; Reiter LT; Chamberlain SJ
Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
[TBL] [Abstract][Full Text] [Related]
13. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
[TBL] [Abstract][Full Text] [Related]
14. Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A.
Sen D; Voulgaropoulos A; Drobna Z; Keung AJ
Stem Cell Reports; 2020 Oct; 15(4):845-854. PubMed ID: 32916124
[TBL] [Abstract][Full Text] [Related]
15. Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells.
Grier MD; Carson RP; Lagrange AH
PLoS One; 2015; 10(4):e0124649. PubMed ID: 25894543
[TBL] [Abstract][Full Text] [Related]
16. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
[TBL] [Abstract][Full Text] [Related]
17. Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.
Pandya NJ; Wang C; Costa V; Lopatta P; Meier S; Zampeta FI; Punt AM; Mientjes E; Grossen P; Distler T; Tzouros M; Martà Y; Banfai B; Patsch C; Rasmussen S; Hoener M; Berrera M; Kremer T; Dunkley T; Ebeling M; Distel B; Elgersma Y; Jagasia R
Cell Rep Med; 2021 Aug; 2(8):100360. PubMed ID: 34467244
[TBL] [Abstract][Full Text] [Related]
18. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
[TBL] [Abstract][Full Text] [Related]
19. Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome.
Egawa K; Kitagawa K; Inoue K; Takayama M; Takayama C; Saitoh S; Kishino T; Kitagawa M; Fukuda A
Sci Transl Med; 2012 Dec; 4(163):163ra157. PubMed ID: 23220633
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling.
Furusawa K; Ishii K; Tsuji M; Tokumitsu N; Hasegawa E; Emoto K
Science; 2023 Sep; 381(6663):1197-1205. PubMed ID: 37708280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
